- call +1-201-465-4211
- email sales@mrinsights.biz
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.
Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.
Scope of the Report:
Humira is widely used for Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s disease and other disease. The most proportion of Humira is for Ankylosing Spondylitis, and the proportion in 2017 is about 43%, and the proportion is in decreasing trend from 2013 to 2017.
USA is the largest market, with a sales market share nearly 65% in 2017. Following USA, Europe is the second largest market with the sales market share of 30%.
The worldwide market for Humira is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Humira in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
AbbVie
Eisai
Cadila Healthcare
Torrent Pharmaceuticals
Amgen
Boehringer Ingelheim
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Humira Syringe
Humira Pen
Market Segment by Applications, can be divided into
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn’s Disease
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Humira product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Humira, with price, sales, revenue and global market share of Humira in 2017 and 2018.
Chapter 3, the Humira competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Humira breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Humira market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Humira sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Humira Introduction
1.2 Market Analysis by Type
1.2.1 Humira Syringe
1.2.2 Humira Pen
1.3 Market Analysis by Applications
1.3.1 Ankylosing Spondylitis
1.3.2 Rheumatoid Arthritis
1.3.3 Crohn’s Disease
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 Business Overview
2.1.2 Humira Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AbbVie Humira Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Eisai
2.2.1 Business Overview
2.2.2 Humira Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eisai Humira Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Cadila Healthcare
2.3.1 Business Overview
2.3.2 Humira Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Cadila Healthcare Humira Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Torrent Pharmaceuticals
2.4.1 Business Overview
2.4.2 Humira Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Torrent Pharmaceuticals Humira Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Amgen
2.5.1 Business Overview
2.5.2 Humira Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Amgen Humira Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Boehringer Ingelheim
2.6.1 Business Overview
2.6.2 Humira Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Boehringer Ingelheim Humira Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Humira Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Humira Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Humira Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Humira Manufacturer Market Share in 2018
3.3.2 Top 6 Humira Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Humira Market Analysis by Regions
4.1 Global Humira Sales, Revenue and Market Share by Regions
4.1.1 Global Humira Sales and Market Share by Regions (2014-2019)
4.1.2 Global Humira Revenue and Market Share by Regions (2014-2019)
4.2 North America Humira Sales and Growth Rate (2014-2019)
4.3 Europe Humira Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Humira Sales and Growth Rate (2014-2019)
4.5 South America Humira Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Humira Sales and Growth Rate (2014-2019)
5 North America Humira by Country
5.1 North America Humira Sales, Revenue and Market Share by Country
5.1.1 North America Humira Sales and Market Share by Country (2014-2019)
5.1.2 North America Humira Revenue and Market Share by Country (2014-2019)
5.2 United States Humira Sales and Growth Rate (2014-2019)
5.3 Canada Humira Sales and Growth Rate (2014-2019)
5.4 Mexico Humira Sales and Growth Rate (2014-2019)
6 Europe Humira by Country
6.1 Europe Humira Sales, Revenue and Market Share by Country
6.1.1 Europe Humira Sales and Market Share by Country (2014-2019)
6.1.2 Europe Humira Revenue and Market Share by Country (2014-2019)
6.2 Germany Humira Sales and Growth Rate (2014-2019)
6.3 UK Humira Sales and Growth Rate (2014-2019)
6.4 France Humira Sales and Growth Rate (2014-2019)
6.5 Russia Humira Sales and Growth Rate (2014-2019)
6.6 Italy Humira Sales and Growth Rate (2014-2019)
7 Asia-Pacific Humira by Country
7.1 Asia-Pacific Humira Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Humira Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Humira Revenue and Market Share by Country (2014-2019)
7.2 China Humira Sales and Growth Rate (2014-2019)
7.3 Japan Humira Sales and Growth Rate (2014-2019)
7.4 Korea Humira Sales and Growth Rate (2014-2019)
7.5 India Humira Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Humira Sales and Growth Rate (2014-2019)
8 South America Humira by Country
8.1 South America Humira Sales, Revenue and Market Share by Country
8.1.1 South America Humira Sales and Market Share by Country (2014-2019)
8.1.2 South America Humira Revenue and Market Share by Country (2014-2019)
8.2 Brazil Humira Sales and Growth Rate (2014-2019)
8.3 Argentina Humira Sales and Growth Rate (2014-2019)
8.4 Colombia Humira Sales and Growth Rate (2014-2019)
9 Middle East and Africa Humira by Countries
9.1 Middle East and Africa Humira Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Humira Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Humira Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Humira Sales and Growth Rate (2014-2019)
9.3 Turkey Humira Sales and Growth Rate (2014-2019)
9.4 Egypt Humira Sales and Growth Rate (2014-2019)
9.5 Nigeria Humira Sales and Growth Rate (2014-2019)
9.6 South Africa Humira Sales and Growth Rate (2014-2019)
10 Global Humira Market Segment by Type
10.1 Global Humira Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Humira Sales and Market Share by Type (2014-2019)
10.1.2 Global Humira Revenue and Market Share by Type (2014-2019)
10.2 Humira Syringe Sales Growth and Price
10.2.1 Global Humira Syringe Sales Growth (2014-2019)
10.2.2 Global Humira Syringe Price (2014-2019)
10.3 Humira Pen Sales Growth and Price
10.3.1 Global Humira Pen Sales Growth (2014-2019)
10.3.2 Global Humira Pen Price (2014-2019)
11 Global Humira Market Segment by Application
11.1 Global Humira Sales Market Share by Application (2014-2019)
11.2 Ankylosing Spondylitis Sales Growth (2014-2019)
11.3 Rheumatoid Arthritis Sales Growth (2014-2019)
11.4 Crohn’s Disease Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Humira Market Forecast (2019-2024)
12.1 Global Humira Sales, Revenue and Growth Rate (2019-2024)
12.2 Humira Market Forecast by Regions (2019-2024)
12.2.1 North America Humira Market Forecast (2019-2024)
12.2.2 Europe Humira Market Forecast (2019-2024)
12.2.3 Asia-Pacific Humira Market Forecast (2019-2024)
12.2.4 South America Humira Market Forecast (2019-2024)
12.2.5 Middle East and Africa Humira Market Forecast (2019-2024)
12.3 Humira Market Forecast by Type (2019-2024)
12.3.1 Global Humira Sales Forecast by Type (2019-2024)
12.3.2 Global Humira Market Share Forecast by Type (2019-2024)
12.4 Humira Market Forecast by Application (2019-2024)
12.4.1 Global Humira Sales Forecast by Application (2019-2024)
12.4.2 Global Humira Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Humira Picture
Table Product Specifications of Humira
Figure Global Sales Market Share of Humira by Types in 2018
Table Humira Types for Major Manufactu
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
